InVivo Therapeutics Holdings Corp
NVIV
NVIV was delisted on the 12th of February, 2024.
19 hedge funds and large institutions have $1.81M invested in InVivo Therapeutics Holdings Corp in 2021 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 4 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 4
10% less funds holding
Funds holding: 21 → 19 (-2)
24% less capital invested
Capital invested by funds: $2.4M → $1.81M (-$587K)
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$166K |
| 2 |
Renaissance Technologies
New York
|
+$87.6K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$68.1K |
| 4 |
Morgan Stanley
New York
|
+$36.3K |
| 5 |
Goldman Sachs
New York
|
+$30.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$166K |
| 2 |
VF
Virtu Financial
New York
|
-$72.2K |
| 3 |
Bank of New York Mellon
New York
|
-$67K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$59K |
| 5 |
Millennium Management
New York
|
-$27.8K |
NVIV Hedge Fund Activity: Q2 2021 in Review
19 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in InVivo Therapeutics Holdings Corp (NVIV) for Q2 2021, worth a combined $1.81M — down 24% from $2.4M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of NVIV and 2 opened new positions — a net loss of 2 holders — while 4 trimmed existing stakes and 6 added.
The largest buyer was State Street, opening a new position worth an estimated $166K. The largest seller was BlackRock, cutting an estimated $166K.
- 19 institutional investors held InVivo Therapeutics Holdings Corp (NVIV) as of Q2 2021, down from 21 in Q1 2021.
- Funds reported $1.81M of InVivo Therapeutics Holdings Corp stock for Q2 2021, down 24% quarter-over-quarter.
- 2 funds opened new InVivo Therapeutics Holdings Corp positions in Q2 2021 and 4 closed out, a net change of -2 holders.
- The largest InVivo Therapeutics Holdings Corp buyer in Q2 2021 was State Street, an estimated $166K added.
- The largest InVivo Therapeutics Holdings Corp seller in Q2 2021 was BlackRock, an estimated $166K sold.
Based on aggregated 13F filings for Q2 2021.